The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


UPDATED: Amid Big Pharma manufacturing squeeze, Merck cuts 112 jobs in Florida plant shutdown

Continental drift claims Singapore, Shanghai units as Novartis revamp shifts R&D westward

Novartis' Cosentyx keeps up the good clearance through Year 4: Study

Troubled psoriasis med brodalumab debuts in Japan with mighty Cosentyx in its sights

Cancer hopeful neratinib plagued by diarrhea, analysis shows, but Puma cites a solution

J&J's Stelara, squeezed in psoriasis, grabs new market with Crohn's approval

Novartis' Ilaris nets a trio of rare-disease nods in untapped markets

Novartis hopes speedy new diagnostic gadget can help boost Xolair scripts

Novartis' new Zykadia data put first-line nod in sight, but a Roche showdown looms

Novartis could snag a blockbuster MS market all for itself, just in time to fight Gilenya generics